Oral medications, including antibiotics or hormonal therapies, might also be prescribed depending on the underlying cause
Joint Pain: Paradoxically, users may experience joint pain, counteracting any performance benefits
Ratios significantly outside the 1:5 to 1:20 range indicate potential formulation issues
Dosing Protocol Suggested weekly titration approach from clinical trials
Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage
Mechanism of Action Comparison IGF-1 LR3 Reduced IGFBP-1, -2, -3 binding affinity Extended circulating half-life (~20-30 hours) Sustained IGF-1 receptor activation Full receptor binding affinity maintained IGF-1 DES Reduced IGFBP binding via truncation Short half-life (~20-30 minutes) Rapid, acute receptor activation Enhanced receptor binding potency reported Research Applications Comparison The choice between IGF-1 LR3 and IGF-1 DES depends on the specific temporal requirements of your research